跳至主要内容
临床试验/NCT04436926
NCT04436926已完成不适用

The Neural Basis of Approach Bias Modification in Opioid Users With Chronic Pain

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Change in reaction time on an opioid approach-avoidance task across time, baseline to end of treatment, week 3

研究概览

简要总结

To investigate the neurobiological mechanisms underlying opioid approach bias during a pilot RCT of opioid approach bias modification. The investigators are combining novel ultra-high field MRI technology with the promising treatment of modifying cognitive bias away from detrimental prescription drug use will generate novel neural data and potentially yield a new therapeutic tool to reduce problematic opioid use.

详细描述

The proposed study is a pilot prospective, parallel groups, randomized, double blind, sham training-controlled, 6-session (over 2 weeks) clinical trial of opioid approach bias modification (OABM) in 20 male and female veterans with chronic pain at high risk for opioid-related adverse events at the San Francisco Veterans Affairs Health Care System, between ages 18-69. The study consists of screening, 2-week cognitive training, Week-3 post-assessment. Assessment of the neurobiological mechanisms of opioid approach bias will be administered at baseline and Week-3.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male and female veterans eligible for VA services
  • •Ages 18-69
  • •Chronic pain (current pain lasting ≥ 90 days)
  • •Prescribed chronic opioids (≥ 90 days in past year)
  • •High risk for opioid-related averse outcomes (≥ 20mg morphine equivalent daily dose).

排除标准

  • •Psychotic, bipolar disorders or other psychiatric disorders judged to be unstable by the PI
  • •Current or past history of the following: intrinsic cerebral tumors, cerebrovascular accident/disease, brain aneurysm, arteriovenous malformations, surgical implantation of neurostimulators or cardiac pacemakers, demyelinating and neurodegenerative diseases, penetrating traumatic brain injury, and any other MRI contraindications.
  • •No female participant will be pregnant or actively attempting to conceive to prevent any unnecessary exposure to high magnetic fields or radio frequency energy to the unborn child.
  • •Concurrent participation in a treatment study
  • •Moderately Severe/Severe withdrawal from opioids based on a score of 25 or more on the Clinical Opiate Withdrawal Scale (COWS)

研究组 & 干预措施

opioid approach bias training

Experimental

Immediately following screening, patients will be randomly assigned to receive 6 sessions of opioid approach bias modification taking place over two weeks.

干预措施: opioid approach bias modification (Behavioral)

sham training

Sham Comparator

Immediately following screening, patients will be randomly assigned to receive 6 sessions of sham training taking place over two weeks.

干预措施: sham training (Behavioral)

结局指标

主要结局

Change in reaction time on an opioid approach-avoidance task across time, baseline to end of treatment, week 3

时间窗: baseline to end of treatment, week 3

millisecond reaction time of (opioid push - opioid pull) - (non-opioid push - opioid pull) on an opioid approach-avoidance task where participants are asked to respond to the format of presented pictures, irregardless of the content. There are two categories of pictures; 20 different opioid pictures and 20 different non-opioid pictures, with two-hundred trials. Millisecond reaction time will be measured at baseline, prior to each training session during the 2-week training period, and at week 3 post training assessment. Primary outcome is change in reaction time across time in active vs. sham condition.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验